Cancer Institute Director. Head & Neck Surgeon. Clinical Researcher focused on #immunotherapy. Relentlessly working to #FinishCancer @Providence Tweets my own
Portland, OR
Joined December 2015
- Tweets3.3K
- Following670
- Followers2.5K
- Likes7.4K
Pinned Tweet
I am deeply honored to succeed Dr. Urba & I am committed to building upon his legacy of transformational immuno-oncology research & a world-class cancer center dedicated to translating the next generation of immunotherapies from lab bench to the bedside. @ChilesResearch
Providence is excited to announce Bryan Bell, M.D., as executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute @ChilesResearch. Walter Urba, M.D., Ph.D., wll retire at the end of the year. blog.providence.org/regional…
To celebrate the birthday of William Shakespeare, I’m sharing a few lines from my most favorite sonnet, Sonnet 116. I’ve converted a few of my friends to its cause, and I’m hoping you’re next. Cheers!
You can hear the entire collection in “Patrick Stewart Performs the Complete Sonnets of William Shakespeare” available now: bit.ly/PatrickStewartSonnets
@SimonAudio
#NationalShakespeareDay
Thanks to Mike Meyer & team for an outstanding #CCX2026! Inspiring discussions with leaders @HutchPresident @CliffordHudis @KimrynRathmell & many others on AI, innovation & cancer outcomes. My takeaway: Measure what matters to patients and ensure access to breakthroughs for all.
A milestone for biomarker-driven neoadjuvant immunotherapy! FDA approval of dostarlimab in dMMR rectal cancer points toward the ultimate goal: response-adapted therapy that may spare patients from surgery, chemo or radiation. #FinishCancer @Providence. fda.gov/news-events/press-an…
Delighted to welcome Prof. Andriy Morgun from @OregonState as our EACRI visiting professor to talk about his work on the microbiome and digital twins. Great talk and wonderful discussion. Looking forward to start of a productive collaboration to #FinishCancer @providence
Prognostic value of baseline modified barium swallow for perioperative dysphagia in oropharyngeal cancer: Secondary analysis of ECOG-ACRIN E3311
sciencedirect.com/science/ar…
Pleased to see @providence included amongst @BeckersHR top health systems with a great oncology program. beckersoncology.com/oncology…
An incredible #EACMFS2026 meeting in Athens! Deeply grateful to Prof. Nicholas Kalavrezos @londonhead_neck for the honor of delivering the Presidential Lecture—and for his friendship & gracious hospitality. Inspired by colleagues from around the world advancing surgical care.
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) retweeted
Phil and Penny Knight have pledged $1.1 billion to create Oregon's first women's hospital and improve cardiac care. bizjournals.com/portland/new…
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) retweeted
Phil and Penny Knight’s largest gift to Providence will create a new women’s hospital at St. Vincent and expand heart care.
What a great day to reach the #FinishCancer line- congratulations to all of the #HoodToCoast2026 particpants! A profound thank you to the 82 fundraising teams who collectively raised more than $1.16M in support of cancer research at @providence cancer institute! 🙏
At the #HoodToCoast exchange near downtown Portland & ran into the #CancerCrushers, an incredible team of @Providence patients & caregivers, including the indomitable @roth_becky. Lots of people run this race who have survived cancer but few run it without fibulas-she’s fibulous!
To the @h2c Race Series team, Dan Floyd and especially to all of the runners, volunteers, donors, and supporters: thank you for going the distance for cancer research.
Race Day! #HoodToCoast, the mother of all relays is underway! Honored to be running in van #2 with the @providence #FinishCancer team, an amazing group of caregivers from our cancer institute and the Earle A. Chiles Research Institute. Go team!
FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer | FDA fda.gov/news-events/press-an…
@moderna_tx , @Merck breakthrough could usher in a new era for cancer vaccines. Congrats to our own Dr. Matthew Taylor who led the trial @providence in Oregon and to all the investigators. #FinishCancer reuters.com/legal/litigation…
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial- congrats @BrendanCurtiMD & @providence team! ascopubs.org/doi/10.1200/JCO…
The final paper from Gough/Crittenden Lab @providence is out in J of Immunology.
Kaede tracking shows the tumor-draining lymph node refills irradiated tumors with T cells — support for lymphatic-sparing immunoradiotherapy in H&N cancer. academic.oup.com/jimmunol/ar…
That's a wrap on @AHNSinfo 12th Int Meeting in Boston. The clear signal: perioperative immunotherapy has emerged as a new paradigm in head and neck oncology.
Honored to share the KEYNOTE-689 stage with @DrUppaluri, @RobertFerrisMD, @DrHaddadRobert & @TMWiseDraper. #AHNS2026
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) retweeted
Congratulations to Dr. Steven Rosenberg on this well-deserved honor recognizing his pioneering work in cancer immunotherapy. His discoveries have transformed cancer treatment and brought hope to patients worldwide. go.nih.gov/txIzeGl
ALT Dr. Steven Rosenberg
Each summer, one of the most rewarding parts of our work at the @Providence Cancer Institute’s Earle A. Chiles Research Institute is welcoming our summer interns, representing the next generation of scientists, physicians, and research leaders. The future of science is bright!
